Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers carbon black, a form of elemental carbon used to enhance the physical properties of the systems and applications in which it is incorporated; and rubber blacks for use as a rubber reinforcing agent and performance additive in tires, hoses, belts, extruded profiles, and molded goods. It also provides compounds of carbon black and rubber primarily for tire applications; and cesium formate, a drilling and completion fluid for use in high pressure and high temperature oil and gas well construction. In addition, the company offers specialty grades of carbon black used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; and fumed silica, fumed alumina, and dispersions for automotive, construction, microelectronics, batteries, and consumer products industries, as well as aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. Further, it provides activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; as a chemical carrier; and as a colorant or a decolorizing agent. The company sells its products primarily through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.
Industry, Sector and Symbol
Industry Miscellaneous chemical products
Sub-IndustryCommodity Chemicals
SectorBasic Materials
SymbolNYSE:CBT
CUSIP12705510
Phone617-345-0100
Debt
Debt-to-Equity Ratio0.47
Current Ratio1.67
Quick Ratio1.07
Price-To-Earnings
Trailing P/E Ratio18.62
Forward P/E Ratio15.54
P/E Growth1.5
Sales & Book Value
Annual Sales$2.72 billion
Price / Sales1.45
Cash Flow$5.9785 per share
Price / Cash10.68
Book Value$25.73 per share
Price / Book2.48
Profitability
EPS (Most Recent Fiscal Year)$3.43
Net Income$241 million
Net Margins-6.14%
Return on Equity15.83%
Return on Assets7.29%
Miscellaneous
Employees4,500
Outstanding Shares61,820,000
Cabot (NYSE:CBT) Frequently Asked Questions
What is Cabot's stock symbol?
Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."
How often does Cabot pay dividends? What is the dividend yield for Cabot?
Cabot declared a quarterly dividend on Wednesday, May 9th. Investors of record on Friday, May 25th will be paid a dividend of $0.33 per share on Friday, June 8th. This represents a $1.32 annualized dividend and a dividend yield of 2.07%. The ex-dividend date of this dividend is Thursday, May 24th. This is a positive change from Cabot's previous quarterly dividend of $0.32. View Cabot's Dividend History.
How were Cabot's earnings last quarter?
Cabot Corp (NYSE:CBT) posted its quarterly earnings results on Monday, May, 7th. The specialty chemicals company reported $1.04 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.00 by $0.04. The specialty chemicals company had revenue of $818 million for the quarter, compared to the consensus estimate of $746.30 million. Cabot had a negative net margin of 6.14% and a positive return on equity of 15.83%. The business's revenue was up 20.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.87 EPS. View Cabot's Earnings History.
When is Cabot's next earnings date?
What price target have analysts set for CBT?
7 brokers have issued 1-year price objectives for Cabot's stock. Their forecasts range from $57.00 to $80.00. On average, they expect Cabot's stock price to reach $72.50 in the next year. View Analyst Ratings for Cabot.
Are investors shorting Cabot?
Cabot saw a drop in short interest during the month of May. As of May 15th, there was short interest totalling 777,931 shares, a drop of 48.5% from the April 30th total of 1,509,562 shares. Based on an average trading volume of 615,944 shares, the short-interest ratio is currently 1.3 days. Currently, 1.3% of the shares of the stock are sold short.
Who are some of Cabot's key competitors?
Who are Cabot's key executives?
Cabot's management team includes the folowing people:
- Mr. Sean D. Keohane, Pres, CEO & Director (Age 51)
- Mr. Eduardo E. Cordeiro, Exec. VP, CFO & Pres of Americas region (Age 51)
- Mr. Brian A. Berube, Sr. VP & Gen. Counsel (Age 56)
- Mr. Nicholas S. Cross, Exec. VP, Pres of Performance Chemicals segment & Pres of EMEA region (Age 57)
- Mr. Hobart C. Kalkstein, Sr. VP & Pres of Reinforcement Materials segment (Age 48)
Has Cabot been receiving favorable news coverage?
Press coverage about CBT stock has been trending somewhat positive this week, Accern reports. Accern ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cabot earned a news sentiment score of 0.20 on Accern's scale. They also assigned headlines about the specialty chemicals company an impact score of 45.05 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
Who are Cabot's major shareholders?
Cabot's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.71%), LSV Asset Management (4.83%), Earnest Partners LLC (2.49%), Dimensional Fund Advisors LP (2.46%), Fiduciary Trust Co. (2.10%) and Victory Capital Management Inc. (1.62%). Company insiders that own Cabot stock include Brian A Berube, Eduardo E Cordeiro, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Michael M Morrow, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Institutional Ownership Trends for Cabot.
Which major investors are selling Cabot stock?
CBT stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., JPMorgan Chase & Co., Prudential Financial Inc., Allianz Asset Management GmbH, Allianz Asset Management GmbH, Victory Capital Management Inc., Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp and Dean Investment Associates LLC. Company insiders that have sold Cabot company stock in the last year include Brian A Berube, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Insider Buying and Selling for Cabot.
Which major investors are buying Cabot stock?
CBT stock was acquired by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Principal Financial Group Inc., Scopus Asset Management L.P., BlackRock Inc., Fiduciary Trust Co., Old Mutual Global Investors UK Ltd., UBS Group AG and State of New Jersey Common Pension Fund D. View Insider Buying and Selling for Cabot.
How do I buy shares of Cabot?
Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cabot's stock price today?
One share of CBT stock can currently be purchased for approximately $63.85.
How big of a company is Cabot?
Cabot has a market capitalization of $3.95 billion and generates $2.72 billion in revenue each year. The specialty chemicals company earns $241 million in net income (profit) each year or $3.43 on an earnings per share basis. Cabot employs 4,500 workers across the globe.
How can I contact Cabot?
Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at 617-345-0100 or via email at [email protected]
MarketBeat Community Rating for Cabot (CBT)
MarketBeat's community ratings are surveys of what our community members think about Cabot and other stocks. Vote "Outperform" if you believe CBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBT will underperform the S&P 500 over the long term. You may vote once every thirty days.
